Array BioPharma: Fiscal 2Q Earnings Snapshot

BOULDER, Colo. (AP) _ Array BioPharma Inc. (ARRY) on Tuesday reported a loss of $11.4 million in its fiscal second quarter.

The Boulder, Colorado-based company said it had a loss of 5 cents per share.

The results beat Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for a loss of 16 cents per share.

The drug developer posted revenue of $82.5 million in the period, which also topped Street forecasts. Six analysts surveyed by Zacks expected $49 million.

Array BioPharma shares have climbed 33 percent since the beginning of the year. The stock has increased 27 percent in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ARRY at https://www.zacks.com/ap/ARRY